Treatment of type 2 diabetes with a combination DPIV and metformin or thiazolidinedione

摘要

A DPIV inhibitor in combination with metformin or a thiazolidinedione for use as first-line therapy for treating type 2 diabetes in a human, wherein the human has not been previously treated with an antidiabetic agent.